Christopher Raymond

Chris Raymond is a managing director and senior research analyst at Piper Sandler covering the biotechnology sector. Prior to joining Piper, he spent the previous 17 years covering biotechnology at Raymond James, Robert W. Baird and Prudential Vector Healthcare Group. Before that, he spent 10 years with Baxter Healthcare and G. D. Searle in various marketing, business development and strategy roles. Raymond has been recognized twice by StarMine as a top earnings estimator in biotechnology and in 2004 was recognized byThe Wall Street Journal "Best on the Street" survey. Raymond received his bachelor’s degree from Michigan State University and his Master of Business Administration degree from the University of Chicago Graduate School of Business. He currently serves on the board of the Financial Markets Institute at Michigan State's Broad College of Business.

Universe Coverage

Biotechnology
ARDX	Ardelyx, Inc.
ITOS	iTeos Therapeutics, Inc.
BMRN	BioMarin Pharmaceutical Inc.
REGN	Regeneron Pharmaceuticals Inc.
DCPH	Deciphera Pharmaceuticals, Inc.
AMGN	Amgen Inc.
BIIB	Biogen Inc.
ABBV	AbbVie Inc.
ALXO	ALX Oncology Holdings, Inc.
RARE	Ultragenyx Pharmaceutical, Inc.
BPMC	Blueprint Medicines Corporation
COGT	Cogent Biosciences, Inc.
OTIC	Otonomy, Inc.
MGTX	MeiraGTx Holdings Plc
KNTE	Kinnate Biopharma, Inc.
INZY	Inozyme Pharma, Inc.
BCRX	BioCryst Pharmaceuticals, Inc.
ACRS	Aclaris Therapeutics, Inc.
NUVL	Nuvalent, Inc.
BHVN	Biohaven Pharmaceutical Holding Company Ltd
KPTI	Karyopharm Therapeutics, Inc.
AGIO	Agios Pharmaceuticals, Inc.
VRTX	Vertex Pharmaceuticals Inc.
IOBT	IO Biotech, Inc.